Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations

J Clin Lipidol. 2022 Sep-Oct;16(5):591-595. doi: 10.1016/j.jacl.2022.07.013. Epub 2022 Jul 31.

Abstract

Familial chylomicronemia syndrome (FCS) is a rare and severe genetic disorder, characterized by marked elevation of plasma triglycerides, often diagnosed in infancy. We describe the long-term follow-up (almost 60 years), the diagnostic assessment and the management of two siblings with severe hypertriglyceridemia and a history of pancreatitis who also developed cardiovascular complications later in life. We recently disclosed that the surviving index case was homozygous for a pathogenic LPL gene variant (c.984 G>T, p.M328I). The same variant was also found in two apparently unrelated siblings with FCS living in the same geographical area as the index case.

Keywords: Atherosclerosis; Familial chylomicronemia syndrome; Genetic analysis; Hypertriglyceridemia; Lipoprotein lipase; Long-term survival; Pancreatitis.

MeSH terms

  • Follow-Up Studies
  • Humans
  • Hyperlipoproteinemia Type I* / diagnosis
  • Hyperlipoproteinemia Type I* / genetics
  • Hypertriglyceridemia* / genetics
  • Lipoprotein Lipase / genetics
  • Siblings

Substances

  • Lipoprotein Lipase

Supplementary concepts

  • Familial hyperchylomicronemia syndrome